Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
80°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Caredx Inc
(NQ:
CDNA
)
31.54
+0.58 (+1.87%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Caredx Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
CareDx Announces Transplant Community Secures Win Reaffirming Longstanding Medicare Coverage for AlloSure and AlloMap Testing
August 16, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Second Quarter 2024 Results and Increases Revenue Guidance
July 31, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx to Report Second Quarter 2024 Financial Results
July 16, 2024
From
CareDx, Inc.
Via
Business Wire
Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable Patients
June 03, 2024
From
CareDx, Inc.
Via
Business Wire
AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress
May 30, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reiterates Position that it Does Not Infringe the ‘544 Patent, Injunction Motion is Irrelevant
May 29, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx to Participate in Upcoming Investor Conferences
May 29, 2024
From
CareDx, Inc.
Via
Business Wire
Landmark Study Shows CareDx’s HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies
May 16, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports First Quarter 2024 Results
May 09, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 03, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx to Report First Quarter 2024 Financial Results
April 29, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
April 19, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer
April 16, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
April 09, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Appoints Bryan Riggsbee to Its Board of Directors
March 11, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Announces Fourth Quarter and Full Year 2023 Financial Results
February 28, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx to Participate in the Raymond James & Associates’ 45th Annual Institutional Investors Conference
February 27, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx to Report Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
February 21, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Issues Statement in Patent Infringement Case
January 26, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Adds to AlloSure Kidney and HeartCare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium
January 11, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023
January 09, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence
December 19, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Third Quarter 2023 Results
November 08, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx to Report Third Quarter 2023 Financial Results
November 02, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Announces CEO Transition
November 01, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Presents New Data at the American Society for Histocompatibility and Immunogenetics Annual Meeting
October 17, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Issues Statement on Supreme Court Decision Regarding Stanford-Licensed Patents
October 03, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx To Present at the 2023 Cantor Global Healthcare Conference
September 19, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx To Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 31, 2023
From
CareDx, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.